World of DTC Marketing

FEBRUARY 21, 2022

didn’t just offer to pay for the drug’s development cost so that the price could be set very low, but it’s about investors who penalized the company stock when they learned that COVID might be on the decline. The post The drug industry continues to dare regulation appeared first on World of DTC Marketing.com.

Regulation 218

Regulation Drugs Bioequivalency Pharmacy 218

Pharmaceutical Technology

JULY 25, 2022

For example, JAK inhibitors are oral drugs that feature a certain complexity, says Jonathan Watanabe, PhD, professor of Clinical Pharmacy at the University of California, Irvine. The FDA knows that developing specialty generics, particularly generic injectable products, can be challenging. The only way forward for generics producers.

Drugs 298

Drugs Manufacturing Production Pharmacy 298

XTalks

FEBRUARY 8, 2021

While there are currently six biosimilars for AbbVie’s Humira (adalimumab) that have been approved by the regulator, the company’s patents prevent biosimilars from being launched until 2023. The regulator allows biosimilars to show slight differences in clinically inactive components of a product.

Production 78

Production Insulin Branding Generic Drugs 78